BMS's third-quarter profits triple
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb'sthird-quarter net profits tripled to $2.58 billion, following the $4.1 billion sale of its wound and surgical business, ConvaTec (Scrip Online, August 6th, 2008). The divestment contributed a $2 billion, or $0.99 per share, after-tax gain to profits.